InvestSMART

Cellmid Limited (ASX: CDY) - Announcements

- Current share price for CDY : $0.056

ASX company news and announcements for Cellmid Limited (CDY) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Cellmid Limited (CDY) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Cellmid Limited (CDY), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Cellmid Limited (CDY)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
- Change of Director's Interest Notice 19 Sep 2016 5:27PM $0.029 $0.056 risen by 93.10%
- Date of Annual General Meeting 13 Sep 2016 2:19PM $0.029 $0.056 risen by 93.10%
- Appendix 4G and Corporate Governance Statement 31 Aug 2016 8:52AM $0.031 $0.056 risen by 80.65%
- Appendix 4E and Preliminary Final Report 30 Aug 2016 5:58PM $0.031 $0.056 risen by 80.65%
- New Publication for Cellmid's Midkine Antibody 9 Aug 2016 11:29AM $0.032 $0.056 risen by 75%
- Cellmid Investor Presentation 3 Aug 2016 9:58AM $0.032 $0.056 risen by 75%
- Transcript of Cellmid Investor Briefing Call 29 Jul 2016 11:41AM $0.034 $0.056 risen by 64.71%
- Appendix 4C - quarterly 26 Jul 2016 11:26AM $0.032 $0.056 risen by 75%
- Ikon Legal Action 22 Jul 2016 5:54PM $0.034 $0.056 risen by 64.71%
- Cellmid Investor Briefing 21 Jul 2016 2:26PM $0.036 $0.056 risen by 55.56%
- USA Distribution Partnership for Cellmid's Evolis 20 Jul 2016 8:51AM $0.031 $0.056 risen by 80.65%
- Change in substantial holding 18 Jul 2016 8:31AM $0.032 $0.056 risen by 75%
- Change in substantial holding 5 Jul 2016 10:15AM $0.032 $0.056 risen by 75%
- Change in substantial holding 4 Jul 2016 2:32PM $0.032 $0.056 risen by 75%
- Change in substantial holding 30 Jun 2016 3:32PM $0.031 $0.056 risen by 80.65%
- Change in substantial holding 29 Jun 2016 12:12PM $0.032 $0.056 risen by 75%
- MIDKINE INTERVIEWS WITH PHARMATELEVISION PUBLISHED 29 Jun 2016 9:45AM $0.031 $0.056 risen by 80.65%
- Becoming a substantial holder 28 Jun 2016 5:31PM $0.031 $0.056 risen by 80.65%
- MK antibody publication and patent in bone healing 24 Jun 2016 10:20AM $0.032 $0.056 risen by 75%
- Change of Director's Interest Notice - Halasz 20 Jun 2016 12:05PM $0.031 $0.056 risen by 80.65%
- CELLMID LAUNCHES EVOLIS PROFESSIONAL PRODUCTS 14 Jun 2016 12:36PM $0.030 $0.056 risen by 86.67%
- Update on Japanese Sales 26 May 2016 10:04AM $0.022 $0.056 risen by 154.55%
- 4th MIDKINE SYMPOSIUM RESULTS 11 May 2016 9:36AM $0.021 $0.056 risen by 166.67%
- Significant Scientific Appointment for Advisory Board Chair 9 May 2016 2:54PM $0.022 $0.056 risen by 154.55%
- Appendix 4C - quarterly 21 Apr 2016 9:48AM $0.021 $0.056 risen by 166.67%

351 - 375 of 530 results

Page 15 of 22

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.